Abstract:BACKGROUND: The improvement in production technology of new materials including artificial ligament reduces material rupture caused by fatigue and histocompatibility-related synovitis and other complications, leading to a wide application of artificial ligament. OBJECTIVE: To evaluate the histocompatibility and clinical curative effects of reconstruction of the anterior cruciate ligament (ACL) of the knee with ligament advanced reinforcement system (LARS) artificial ligament using arthroscopy. DESIGN: A completely randomized clinical design. SETTING: Department of Orthopedics, Second Affiliated Hospital of Soochow University. PARTICIPANTS: Thirty-two cases of ACL injury received LARS artificial ligament in the Department of Orthopedics, Second Affiliated Hospital of Soochow University From June 2005 to June 2006 and were recruited for this study. The 32 patients averaged 21 years old and were injured in sports. Prior to surgery, MRI showed injury to ACL and semilunar valve in all patients. Written informed consent for therapeutic contents was obtained from each patient. METHODS: Thirty-two patients with injury to ACL of the knee underwent arthroscopic ACL reconstruction. LARS was used to reconstruct the ACL. The LARS was produced by Laboratoire d'Application et de Recherche Scientifique, France (Certification No. CE0459, 1SO9002-EN46002). Artificial ligament was made of polyethylene terephthalate, which had the material type L021201 (left knee) and L021202 (right knee). Artificial ligament was designed to imitate the anatomic structure and biomechanical principle of artificial ligament with specification No. AC120 2BL(left knee) and No. AC120 2BR(right knee). The lot number for artificial ligament in China [import 03460468 (in 2004)]. All reconstructions were performed by a group of physicians who have worked for more than 10 years in the Department of Orthopedics, Second Affiliated Hospital of Soochow University and directed by a physician titled with doctor's tutor and chief physician. All included physicians were qualified to perform the surgery. The protocol of treatment was approved by the hospital's Ethics Committee. MAIN OUTCOME MEASURES: Biocompatibility of LARS artificial ligament was observed. Patients were followed up for 24 months on average to score knee function by Lysholm test and subjective satisfaction by Tegner test. RESULTS: All of 32 cases were followed up. The follow-up periods were 18 months (3 cases), 20 months (7 cases), 24 months (8 cases), 28 months (12 cases) and 30 months (2 cases). No complications, such as acute or chronic synovitis, LARS artificial ligament rupture, or limited range of motion were found. The knee joint function was ideal with the range of motion [0° to (128±11.56)°]. The postoperative scores with 85.6 ± 2.24 were significandy higher than the preoperative scores with 45.3±1.31 according to the Lysholm knee joint function evaluation system (P < 0.05). The instability of every knee disappeared with anterior drawer sign negative. Tegner's scores were also increased. CONCLUSION: The biocompatibility of LARS is optimal. LARS artificial ligament reconstruction showed excellent knee joint function and subjective satisfaction degree.

Follow-up of the posterior cruciate ligament injury treated by arthroscopic reconstruction of ligament advanced reinforcement system

A CLINICAL REPORT ON ARTHROSCOPIC RECONSTRUCTION OF POSTERIOR CRUCIATE LIGAMENT USING LIGAMENT ADVANCED REINFORCEMENT SYSTEM

Arthroscopic posterior cruciate ligament reconstruction using LARS artificial ligament: a retrospective study.

Functional outcome and quality of life of posterior cruciate ligament reconstruction with artificial LARS ligament

Arthroscopic reconstruction of the anterior cruciate ligament using ligament advanced reinforcement system artificial ligament

Anterior Cruciate Ligament Reconstruction Using Ligament Advanced Reinforcement System Artificial Ligament in 28 Cases

[Short-Term Effectiveness of Anterior Cruciate Ligament Reconstruction with LARs Artificial Ligament].

Mid-term Clinical Results of Ligament Advanced Reinforcement System Artificial Ligament in Anterior Cruciate Ligament Reconstruction

Arthroscopic Reconstruction of the Anterior Cruciate Ligament with the LARS Artificial Ligament: Thirty-Six to Fifty-Two Months Follow-Up Study.

ACL Arthroscopic Reconstruction with LARS Artificial Ligament

Hamstring tendon autograft versus LARS artificial ligament for arthroscopic posterior cruciate ligament reconstruction in a long-term follow-up

The Promotive Effect of Grafts with the Double-Stranded Peroneus Longus Tendon and with the Four-Stranded Hamstring Tendon on Reconstruction of the Posterior Cruciate Ligament Injury.

A Follow-Up Study of Arthroscopic Combined Reconstruction of Anterior and Posterior Cruciate Ligaments with Allograft Patellar Tendon.

Arthroscopic Reconstruction of the Posterior Cruciate Ligament Using Single-Bundle Bone-Patella Tendon-Bone Graft with Moderate to Long Term Follow-Up

ARTHROSCOPIC SINGLE BUNDLE POSTERIOR CRUCIATE LIGAMENT RECONSTRUCTION USING HAMSTRING TENDONS THROUGH POSTERIOR TRANS-SEPTUM PORTAL APPROACH WITH PRESERVATION OF REMNANT POSTERIOR CRUCIATE LIGAMENT FIBERS

Early efficacy of arthroscopic posterior cruciate ligament reconstruction with tendon through remnant fiber slit

[Efficacy comparison between a new generation of artificial ligaments and bone-patellar tendon-bone autograft for anterior cruciate ligament revision].

Therapeutic evaluation of arthroscopic reconstruction of posterior cruciate ligament with autogenous hamstring tendons fixed by bioabsorbable screws

Comparison of Early Clinical Outcome Between the Ligament Advanced Reinforcement System and the Γ-Ray Irradiation Allograft for Anterior Cruciate Ligament Reconstruction under Arthroscopy

One-stage arthroscopic reconstruction of anterior and posterior cruciate ligaments:A mid-and long-term curative effect of autograft versus allograft

[Initial Therapeutic Evaluation of Arthroscopic Reconstruction of Anterior and Posterior Cruciate Ligament Injury with Anterior Tibialis Tendon Allograft].